Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy

NIAID Data Ecosystem2026-05-01 收录

晚期胃肠道肿瘤联合治疗

Trop-2生物标志物相关性

数据链接：

https://www.omicsdi.org/dataset/ecrin-mdr-crc/107815 数据链接链接失效反馈

官方服务：

资源简介：

This is a Phase I study to evaluate the safety and tolerability of sacituzumab govitecan in combination with capecitabine for advanced gastrointestinal cancers after progression on standard therapy, and to assess correlation of outcomes with the biomarker Trop-2.

创建时间：

2023-10-15

Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy

资源简介：

相关数据集